ES2173109T3 - Alimentos de unso medico destinados parael sostenimiento nutricional de recien nacidos/de bebes que padecen enfermedades metabolicas. - Google Patents

Alimentos de unso medico destinados parael sostenimiento nutricional de recien nacidos/de bebes que padecen enfermedades metabolicas.

Info

Publication number
ES2173109T3
ES2173109T3 ES94901392T ES94901392T ES2173109T3 ES 2173109 T3 ES2173109 T3 ES 2173109T3 ES 94901392 T ES94901392 T ES 94901392T ES 94901392 T ES94901392 T ES 94901392T ES 2173109 T3 ES2173109 T3 ES 2173109T3
Authority
ES
Spain
Prior art keywords
metabolic diseases
understanded
sustainment
newborns
babies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94901392T
Other languages
English (en)
Inventor
Phyllis Jean Brown Acosta
Richard Andrew Grondalski
Jeffrey Wayne Liebrecht
Patricia Ann Reynolds
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2173109T3 publication Critical patent/ES2173109T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE GENERALMENTE A UNA NUEVA BASE GENERICA EN POLVO RICA EN GRASAS, CARBOHIDRATOS, VITAMINAS, MINERALES Y ELEMENTOS DE TRAZA QUE PUEDEN MEZCLARSE CON AMINOACIDOS ESPECIFICOS PARA DAR COMO RESULTADOS PRODUCTOS TERAPEUTICOS DIFERENTES PARA SU USO EN EL SOPORTE NUTRICIONAL DE NIÑOS/ADULTOS QUE TENGAN DIFERENTES ENFERMEDADES METABOLICAS.
ES94901392T 1992-12-23 1993-11-10 Alimentos de unso medico destinados parael sostenimiento nutricional de recien nacidos/de bebes que padecen enfermedades metabolicas. Expired - Lifetime ES2173109T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99727892A 1992-12-23 1992-12-23

Publications (1)

Publication Number Publication Date
ES2173109T3 true ES2173109T3 (es) 2002-10-16

Family

ID=25543828

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94901392T Expired - Lifetime ES2173109T3 (es) 1992-12-23 1993-11-10 Alimentos de unso medico destinados parael sostenimiento nutricional de recien nacidos/de bebes que padecen enfermedades metabolicas.

Country Status (7)

Country Link
US (2) US5587399A (es)
EP (1) EP0675725B1 (es)
AU (1) AU679020B2 (es)
CA (1) CA2143420C (es)
DE (1) DE69331528T2 (es)
ES (1) ES2173109T3 (es)
WO (1) WO1994014458A1 (es)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629023A (en) * 1991-12-31 1997-05-13 Bland; Jeffrey S. Medical food composition for metabolic detoxification
GB2289406A (en) * 1994-04-15 1995-11-22 Britannia Health Products Ltd Vitamin, betacarotene and zinc composition for sperm health
CN1087171C (zh) * 1996-04-24 2002-07-10 北京市集才药物研究所 适合中国人的多种维生素和矿物质/微量元素复合制剂
JPH1053521A (ja) * 1996-08-12 1998-02-24 Kagaku Gijutsu Shinko Jigyodan 脳内グルタミン酸の活性抑制剤および活性増強剤
DE19654822C1 (de) * 1996-12-24 1998-06-10 Univ Leipzig Mittel zur Prävention defizitbedingter Infektions- und Alterserkrankungen
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
BR9808088A (pt) * 1997-03-27 2000-03-08 Michael J Sole Suplemento nutricional, uso do mesmo e métodos de tratamento de um sistema orgânico crìtico e de insuficiência cardìaca congestiva
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
FR2765481B1 (fr) * 1997-07-07 2000-12-08 Jacques Bogart Sa Complexe amino-lipidique vitamine
US5922361A (en) * 1997-08-11 1999-07-13 Bieser; Albert Howard Folic acid enriched dietary supplement compositions for self-regulating stress-reduction
FR2771259B1 (fr) * 1997-11-21 2000-01-28 Nutriset Aliment complet ou supplement nutritionnel stable vis a vis de l'oxydation, a haute valeur energetique, basse osmolalite, faible teneur en eau, son procede de preparation et ses utilisations
US6194379B1 (en) 1998-05-01 2001-02-27 Abbott Laboratories Elemental enteral formula
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
DE19856789A1 (de) * 1998-12-09 2000-06-15 Nutricia Nv Thymuswachstumsstimulierende Säuglingsnahrung
WO2000064283A1 (en) * 1999-04-27 2000-11-02 International Health Products And Services Ltd. Supplement for restoring growth hormone levels
US6627213B2 (en) 1999-08-20 2003-09-30 Wisconsin Alumni Research Foundation Inhibition of neonatal hyperbilirubinemia in breast fed infants
CA2383100A1 (en) 1999-08-20 2001-03-01 Wisconsin Alumni Research Foundation Aspartic and malic acid inhibition of .beta.-glucuronidase
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
DE60118888T3 (de) * 2000-02-04 2010-09-23 Société des Produits Nestlé S.A. Verfahren zur erhöhung bzw. verbesserung der synthese von mucin
US6476010B2 (en) 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
SK284948B6 (sk) * 2000-04-06 2006-03-02 Zentiva, A. S. Liečivý prípravok s obsahom vápnika alebo zmesi vápnika a vitamínu D, alebo zmesi vápnika a horčíka v novej liekovej forme
GB0009056D0 (en) 2000-04-12 2000-05-31 Nestle Sa Composition comprising free amino acids
CA2405377C (en) * 2000-04-18 2014-04-01 Societe Des Produits Nestle S.A. Nutritional modules
BR0004436A (pt) * 2000-08-25 2002-04-02 Univ Minas Gerais Complemento dietético de aminoácidos, processo para tratamento e prevenção de doenças e processo de administração de um complemento dietético de aminoácidos
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
HRP20020702A2 (en) * 2001-02-14 2004-02-29 Matthias Rath Composition of biochemical compounds involved in bioenergy metabolism of cells
KR100753879B1 (ko) * 2001-06-08 2007-09-03 리가가쿠 겐큐쇼 체온 상승성 아미노산군 음식용 제제
AU2002319961A1 (en) * 2001-07-27 2003-02-17 N.V. Nutricia Enteral compositions for the prevention and/or treatment of sepsis
US20030129262A1 (en) * 2001-08-30 2003-07-10 Epner Daniel E. Methionine restriction for cancer therapy
GB2381451A (en) * 2001-11-01 2003-05-07 New Technology Res Ltd Pharmaco-dietary preparation having nutrition-supplementing and nutrition-enhancing effect
US6503530B1 (en) * 2001-11-01 2003-01-07 Chunghee Kimberly Kang Method of preventing development of severe metabolic derangement in inborn errors of metabolism
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20040197401A1 (en) * 2002-06-14 2004-10-07 Calton Gary J Modifying undesirable tastes
US6592908B1 (en) 2002-09-23 2003-07-15 Albert Crum Nutritional or therapeutic compositions
US20040156882A1 (en) * 2002-10-23 2004-08-12 Davenport David F. Method and composition for feeding mammals
US20040213838A1 (en) * 2003-04-24 2004-10-28 Mazer Terrence B. Medical food tablets containing free amino acids
WO2005110123A1 (en) * 2003-04-25 2005-11-24 Abbott Laboratories Stable nutritional powder containing ascorbyl palmitate
US7332178B2 (en) 2003-04-25 2008-02-19 Abbott Laboratories Stable nutritional powder containing ascorbyl palmitate
US7110827B2 (en) * 2003-04-25 2006-09-19 Medtronic, Inc. Electrical connectors for medical lead having weld-less wiring connection
US8017160B2 (en) 2003-08-15 2011-09-13 Russell Jaffe Enhancement of magnesium uptake in mammals
WO2006009437A2 (en) * 2004-07-19 2006-01-26 N.V. Nutricia Use of aspartate for regulating glucose levels in blood
US7618669B2 (en) * 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
US20060286208A1 (en) * 2005-06-01 2006-12-21 Nagendra Rangavajla Methods for producing protein partial hydrolysates and infant formulas containing the same
GB2437918B (en) * 2006-05-09 2011-02-09 Multi Functional Developments Ltd A ready-to-drink product
DE102009032034A1 (de) 2009-06-26 2010-12-30 Aesculap Ag Chirurgische Knochenverankerungsvorrichtung und Wirbelsäulenfixationssystem
WO2011119023A1 (en) 2010-03-26 2011-09-29 N.V. Nutricia Low protein infant formula with increased essential amino acids
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US9578892B2 (en) * 2011-09-13 2017-02-28 James W. Hill Protein restriction for disease prevention and treatment
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
AU2013354356B2 (en) 2012-12-04 2018-12-06 Société des Produits Nestlé S.A. Trimethylamine-N-oxide as biomarker for the predisposition for weight gain and obesity
AU2013354357B2 (en) * 2012-12-04 2019-02-28 Société des Produits Nestlé S.A. Isovalerylglycine as biomarker for the predisposition for weight gain and obesity
WO2014086603A1 (en) 2012-12-04 2014-06-12 Nestec S.A. Hexanoylglycine as biomarker for the predisposition for weight gain and obesity
CN105074460B (zh) 2013-03-28 2018-06-15 雀巢产品技术援助有限公司 作为用于重量增加预防的益生元功效的生物标记物的硫酸吲哚酚
CN105074457B (zh) 2013-03-28 2019-05-17 雀巢产品技术援助有限公司 作为用于预防重量增加的益生元功效的生物标记物的α-酮-异戊酸
US9414619B2 (en) * 2014-02-06 2016-08-16 Cambrooke Therapeutics, Inc. Liquid nutritional formula for phenylketonuria patients
US10124036B2 (en) * 2015-06-12 2018-11-13 Cambrooke Therapeutics, Inc. Liquid nutritional formula for tyrosinemia patients
WO2016205489A1 (en) * 2015-06-18 2016-12-22 Cambrooke Therapeutics, Inc. Formula for management of phenylketonuria
CN108541215A (zh) * 2016-02-11 2018-09-14 雀巢产品技术援助有限公司 维生素组合物
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
EP3668499A1 (en) 2017-08-14 2020-06-24 Axcella Health Inc. Amino acid compositions for the treatment of liver disease
US11542078B2 (en) * 2017-11-09 2023-01-03 Dr. Schar S.P.A. Device and method for the preparation and oral administration of a liquid composition
WO2019246225A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
AU2019288371A1 (en) 2018-06-20 2020-12-03 Axcella Health Inc. Methods of manufacturing amino acid compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2038629A (en) * 1978-11-17 1980-07-30 Powell & Scholefield Ltd Dietary compositions
US4252822A (en) * 1979-12-26 1981-02-24 Children's Hospital Medical Center Method for treating phenylketonuria
US4340592A (en) * 1980-03-14 1982-07-20 Adibi Siamak A Nutrient compositions and method of administering the same
JPS57113850A (en) * 1980-12-29 1982-07-15 Sumitomo Heavy Ind Ltd Removing device for suspended solids of ore dressing and coal washing machine
JPS58165742A (ja) * 1982-03-25 1983-09-30 Meiji Milk Prod Co Ltd 尿素サイクル異常乳幼児用栄養組成物
JPS58180429A (ja) * 1982-04-16 1983-10-21 Meiji Milk Prod Co Ltd ホモシスチン尿症乳幼児用栄養調製物
JPS595111A (ja) * 1982-07-02 1984-01-12 Meiji Milk Prod Co Ltd フエニ−ルケトン尿症乳幼児用栄養調製物
JPS5953429A (ja) * 1982-09-22 1984-03-28 Meiji Milk Prod Co Ltd 楓糖尿症乳幼児用栄養調製物
US5034377A (en) * 1984-11-19 1991-07-23 Montefiore Hospital Association Of Western Pennsylvania Aqueous nutrient compositions comprising oligopeptides
DE58903342D1 (de) * 1988-10-22 1993-03-04 Vaw Ver Aluminium Werke Ag Rolladenstab zur verwendung in schallgedaempften rollaeden.
GB8906158D0 (en) * 1989-03-17 1989-05-04 Powell & Scholefield Limited Dietary product
FR2668039B1 (fr) * 1990-10-18 1993-06-25 Pernod Ricard Boisson dietetique destinee a permettre de soutenir l'effort.
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids

Also Published As

Publication number Publication date
US5550146A (en) 1996-08-27
CA2143420C (en) 1999-01-19
AU679020B2 (en) 1997-06-19
AU5599194A (en) 1994-07-19
EP0675725A4 (en) 1995-08-12
EP0675725B1 (en) 2002-01-30
WO1994014458A1 (en) 1994-07-07
US5587399A (en) 1996-12-24
DE69331528T2 (de) 2002-10-31
DE69331528D1 (de) 2002-03-14
CA2143420A1 (en) 1994-07-07
EP0675725A1 (en) 1995-10-11

Similar Documents

Publication Publication Date Title
ES2173109T3 (es) Alimentos de unso medico destinados parael sostenimiento nutricional de recien nacidos/de bebes que padecen enfermedades metabolicas.
ES2165870T3 (es) Alimentos de uso medico destinados para el mantenimiento nutricional de niños/adultos que padecen enfermedades metabolicas.
ATE147592T1 (de) Vitamine und mineralien enthaltende nahrungszusätze
DE60032781D1 (de) Nahrungsmittelzusatz zur zunahme der fettarmen körpermasse und kraft
ES2168157T3 (es) Alimento o suplemento nutritivo, su procedimiento de preparacion y sus utilizaciones.
AR028630A1 (es) Un producto alimenticio para mascotas y metodo para prepararlo
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
DK1455603T3 (da) Stimulering af in vivo produktion af proteiner med en formulering, der omfatter leucin
CL2004001550A1 (es) Formula para infantes o para etapa siguiente del crecimiento, que comprende proteinas, lipidos, carbohidratos y un probiotico, en donde la fuente de lipidos incluye al menos un lc-pufa, y sus usos.
PT923315E (pt) Formula nutricional para pacientes com fenilcetonuria
DE3882750D1 (de) Zusammensetzungen von gerste- und nesselextrakten, die als nahrungsmittelzusatz benoetigt werden oder pharmazeutische zubereitung in der menschlichen gesundheitspflege.
AR047649A1 (es) Composicion nutricional para mejorar la condicion de la piel e impedir las enfermedades de la piel
ES2162586A1 (es) Composicion que comprende aceites ozonizados y/o otros productos naturales y/o sinteticos ozonizados, y su empleo en composiciones farmaceuticas, cosmeticas, dieteticas o de suplementos alimentarios, en los campos humano y veterinario
ES2195902T3 (es) Composicion que comprende esfingomielinasa alcalina para uso como preparacion dietetica, complemento alimenticio o producto farmaceutico.
BR0213124A (pt) Alimentos para animais incluindo ativos e métodos de uso dos mesmos
DE602004016301D1 (de) Tablette mit wasserabsorbierender aminosäure
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
ES2179485T3 (es) Composicion solida adecuada para la administracion oral, que contiene fumarato de l-carnitina magnesio, o fumarato de alcanoil-l-carnitina magnesio.
CL2004000813A1 (es) Composicion farmaceutica o dietetica que comprende vitaminas, minerales, oligoelementos, acido docosahexanoico (dha) y un vehiculo apropiado, su uso y metodo para suplementar las necesidades dieteticas de una mujer que esta amamantando, esta embaraza
MX9305143A (es) Composiciones nutritivas o medicamentos a base de quitosana, para la administracion de los rumiantes y procedimiento para su preparacion.
Koletzko et al. Fatty acid composition of plasma lipids in acrodermatitis enteropathica before and after zinc supplementation
ATE308989T1 (de) Zubereitung für oral zu verabreichende nahrungsergänzungs- und/oder arznelmittel in form von tabletten
ES2169915T3 (es) Composicion utilizable en los ambitos farmaceutico, dietetico y cosmetico.
CN103637967A (zh) 美白面膜
Callaway et al. Statement on vitamin and mineral supplements: the Joint Public Information Committee of the American Institute of Nutrition and the American Society for Clinical Nutrition

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 675725

Country of ref document: ES